{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:00:58Z","timestamp":1789016458490,"version":"build-2803163510"},"reference-count":23,"publisher":"American Society of Hematology","issue":"3","license":[{"start":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T00:00:00Z","timestamp":1703548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,2,13]]},"DOI":"10.1182\/bloodadvances.2023011997","type":"journal-article","created":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T21:07:32Z","timestamp":1703624852000},"page":"780-784","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":6,"title":["Specificity of immunoglobulin high-throughput sequencing minimal residual disease monitoring in non-Hodgkin lymphomas"],"prefix":"10.1182","volume":"8","author":[{"given":"Navika D.","family":"Shukla","sequence":"first","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph G.","family":"Schroers-Martin","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Sworder","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan Raj","family":"Kathuria","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan K.","family":"Alig","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Frank","sequence":"additional","affiliation":[{"name":"2Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0717-4305","authenticated-orcid":false,"given":"David B.","family":"Miklos","sequence":"additional","affiliation":[{"name":"2Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Coutre","sequence":"additional","affiliation":[{"name":"3Division of Hematology, Department of Medicine, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Diehn","sequence":"additional","affiliation":[{"name":"4Department of Radiation Oncology, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9061-7351","authenticated-orcid":false,"given":"Michael S.","family":"Khodadoust","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0278-2635","authenticated-orcid":false,"given":"Mark","family":"Roschewski","sequence":"additional","affiliation":[{"name":"5Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6382-4651","authenticated-orcid":false,"given":"David M.","family":"Kurtz","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5153-5625","authenticated-orcid":false,"given":"Ash A.","family":"Alizadeh","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Stanford University, Stanford, CA"},{"name":"3Division of Hematology, Department of Medicine, Stanford University, Stanford, CA"},{"name":"6Stanford Cancer Institute, Stanford University, Stanford, CA"},{"name":"7Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,2,2]]},"reference":[{"issue":"34","key":"2024021217144888300_bib1","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1200\/JCO.2015.62.0229","article-title":"Routine imaging for diffuse large B-cell lymphoma in first complete remission does not improve post-treatment survival: a Danish-Swedish population-based study","volume":"33","author":"El-Galaly","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"2024021217144888300_bib2","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/ajh.22126","article-title":"Utility of positron emission tomography scans in mantle cell lymphoma","volume":"86","author":"Hosein","year":"2011","journal-title":"Am J Hematol"},{"issue":"31","key":"2024021217144888300_bib3","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1200\/JCO.2014.55.7561","article-title":"Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma","volume":"32","author":"Thompson","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"2024021217144888300_bib4","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1470-2045(15)70106-3","article-title":"Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study","volume":"16","author":"Roschewski","year":"2015","journal-title":"Lancet Oncol"},{"issue":"364","key":"2024021217144888300_bib5","doi-asserted-by":"crossref","first-page":"364ra155","DOI":"10.1126\/scitranslmed.aai8545","article-title":"Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA","volume":"8","author":"Scherer","year":"2016","journal-title":"Sci Transl Med"},{"issue":"24","key":"2024021217144888300_bib6","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1182\/blood-2015-03-635169","article-title":"Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing","volume":"125","author":"Kurtz","year":"2015","journal-title":"Blood"},{"issue":"34","key":"2024021217144888300_bib7","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1200\/JCO.2017.74.5281","article-title":"Minimal residual disease assessment in lymphoma: methods and applications","volume":"35","author":"Herrera","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"16","key":"2024021217144888300_bib8","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1182\/blood-2009-06-230250","article-title":"Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study","volume":"115","author":"Pott","year":"2010","journal-title":"Blood"},{"issue":"26","key":"2024021217144888300_bib9","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1182\/blood-2012-07-444042","article-title":"Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia","volume":"120","author":"Faham","year":"2012","journal-title":"Blood"},{"issue":"26","key":"2024021217144888300_bib10","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM198312293092601","article-title":"Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms","volume":"309","author":"Arnold","year":"1983","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"2024021217144888300_bib11","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/nbt.2782","article-title":"The promise and challenge of high-throughput sequencing\u00a0of the antibody repertoire","volume":"32","author":"Georgiou","year":"2014","journal-title":"Nat Biotechnol"},{"issue":"4","key":"2024021217144888300_bib12","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ajhg.2013.03.004","article-title":"Complete haplotype sequence of the human immunoglobulin heavy-chain variable, diversity, and joining genes and characterization of allelic and copy-number variation","volume":"92","author":"Watson","year":"2013","journal-title":"Am J Hum Genet"},{"key":"2024021217144888300_bib13","volume-title":"Immunobiology: The Immune System in Health and Disease","author":"Charles","year":"2001","edition":"5th Edition"},{"issue":"1","key":"2024021217144888300_bib14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40164-022-00300-2","article-title":"Next-generation sequencing for MRD monitoring in B-lineage malignancies: from bench to bedside","volume":"11","author":"Deng","year":"2022","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"2024021217144888300_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13045-020-00961-8","article-title":"Advances in the assessment of minimal residual disease in mantle cell lymphoma","volume":"13","author":"Jung","year":"2020","journal-title":"J\u00a0Hematol Oncol"},{"issue":"1","key":"2024021217144888300_bib16","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1186\/s12885-020-07077-9","article-title":"Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma","volume":"20","author":"Ching","year":"2020","journal-title":"BMC Cancer"},{"issue":"17","key":"2024021217144888300_bib17","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1182\/bloodadvances.2022007706","article-title":"Minimal residual disease in\u00a0patients with diffuse large B-cell lymphoma undergoing autologous\u00a0stem cell transplantation","volume":"7","author":"Merryman","year":"2023","journal-title":"Blood Adv"},{"key":"2024021217144888300_bib18","first-page":"bloodadvances.2023009856","article-title":"Next-generation sequencing-based MRD in adults with ALL undergoing hematopoietic cell transplantation","author":"Liang","year":"17, 2023","journal-title":"Blood Adv"},{"issue":"11-12","key":"2024021217144888300_bib19","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.2119\/molmed.2011.00104","article-title":"Mutation pattern of paired immunoglobulin heavy and light variable domains in chronic lymphocytic leukemia B cells","volume":"17","author":"Ghiotto","year":"2011","journal-title":"Mol Med"},{"key":"2024021217144888300_bib20","unstructured":"immuneACCESS Data. Accessed 25 March 2023. https:\/\/clients.adaptivebiotech.com\/immuneaccess."},{"issue":"Web Server issue","key":"2024021217144888300_bib21","doi-asserted-by":"crossref","first-page":"W503","DOI":"10.1093\/nar\/gkn316","article-title":"IMGT\/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis","volume":"36","author":"Brochet","year":"2008","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"2024021217144888300_bib22","first-page":"656","article-title":"BLAT\u2014the BLAST-like alignment tool","volume":"12","author":"Kent","year":"2002","journal-title":"Genome Res"},{"key":"2024021217144888300_bib23","first-page":"10.8.1","article-title":"Using BLAT to find sequence similarity in closely related genomes","volume":"Chapter 10","author":"Bhagwat","year":"2012","journal-title":"Curr Protoc Bioinformatics"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/3\/780\/2212823\/blooda_adv-2023-011997-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/3\/780\/2212823\/blooda_adv-2023-011997-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T17:15:28Z","timestamp":1707758128000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/3\/780\/506734\/Specificity-of-immunoglobulin-high-throughput"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,2]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,2,13]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023011997","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,2]]}}}